Keller Rohrback Wins Law360 Practice Groups of the Year for Benefits and Product Liability 

January 18, 2022
Group of people celebrating

We are thrilled to announce that Law360, the preeminent publication for legal news and analysis, has selected Keller Rohrback L.L.P. as one of their 2021 “Practice Groups of the Year” award winners in both the Benefits and Product Liability categories. The awards honor “the attorney teams behind litigation wins and major deals that resonated throughout the legal industry this past year.”

This is the second year in a row in which Keller Rohrback’s employee benefit team received the Benefit category award.  The achievements for which the employee benefit team received consideration in this award category were: their work on the Smith v. OSF HealthCare System settlement and their work relating to the Ninth Circuit Panel Decision and Order Denying Petition for Rehearing En Banc in ERISA Industry Committee v. City of Seattle

Keller Rohrback’s nationally recognized complex litigation team also received this honor for their work in the products liability category. The achievements for which Keller Rohrback received consideration in this award category were:  their contribution to litigation successes in In Re National Prescription Opiate Litigation, MDL No. 2804, their work on the proposed settlement in Stringer et al. v. Nissan of North America et al., their appointment as Co-Lead counsel in the In Re Chevrolet Bolt EV Battery Litigation, MDL No. 2987, their appointment as Settlement Counsel in In Re Hyundai and Kia Engine Litigation II, and their work in In Re JUUL Labs, Inc. Marketing, Sales Practices, & Products Liability Litigation wherein Plaintiffs survived three rounds of motions to dismiss.  The Law360 story detailing Keller Rohrback's work that earned them the award can be viewed here.

In addition to the achievements that were considered for this award, Keller Rohrback has had multiple other significant recent achievements in the category of products liability including a $345 Million settlement with Pfizer in In Re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices Antitrust Litigation, MDL No. 2785 and a significant 9th Circuit Court victory relating to class certification in In Re Arizona Theranos, Inc. Litigation.

Law360 selected the winning groups for these awards across 39 practice areas from nearly 900 submissions and Keller Rohrback is honored to be recognized amongst the very best in the industry in these areas. Congratulations to the Keller Rohrback Benefits and Product Liability teams on their hard-won awards and well-deserved recognition!


About Keller Rohrback L.L.P.

Keller Rohrback’s Complex Litigation Group represents plaintiffs in large-scale cases involving corporate wrongdoing. We litigate against companies that pollute, commit fraud, fix prices and take advantage of consumers, employees, and investors. We are passionate advocates for justice. In addition, the Complex Litigation Group regularly calls on attorneys in the firm’s other practice areas for expertise in areas such as bankruptcy, constitutional law, corporate transactions, financial institutions, insurance coverage and intellectual property. Our group’s access to these in-house resources distinguishes Keller Rohrback from other plaintiffs’ class action firms and contributes to the firm’s success. We also have a history of working with legal counsel from other countries to vigorously pursue legal remedies on behalf of clients around the globe.

We have won verdicts in state and federal courts throughout the nation and have obtained judgments and settlements on behalf of clients in excess of $26.3 billion. Courts around the country have praised our work, and we are regularly appointed lead counsel in nationally prominent class action cases. Our work has had far-reaching impacts for our clients in a variety of settings and industries, creating a better, more accountable society.